Closed-loop insulin therapy improves glycemic control in children aged <7 years: A randomized controlled trial

Diabetes Care

Volumn 36, Issue 2, 2013, Pages 222-227

  Dauber, Andrew ^a   Corcia, Liat ^a   Safer, Jason ^a   Agus, Michael S D ^a   Einis, Sara ^a   Steil, Garry M ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; CHILD HEALTH CARE; CLINICAL ARTICLE; CLOSED LOOP INSULIN INFUSION; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MALE; OPEN LOOP INSULIN INFUSION; POSTPRANDIAL STATE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; STANDARD; TIME SERIES ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME;

BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERGLYCEMIA; INSULIN; MALE;

EID: 84873819299     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1079     Document Type: Article

References (24)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-986
2. Hovorka R. Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol 2011;7:385-395
3. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med 2010;2:27ra27
4. Hovorka R, Allen JM, Elleri D, et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010;375:743-751
5. Steil GM, Palerm CC, Kurtz N, et al. The effect of insulin feedback on closed loop glucose control. J Clin Endocrinol Metab 2011;96:1402-1408
6. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 2006;55:3344-3350
7. Weinzimer SA, Steil GM, SwanKL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semi-automated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31:934-939
8. Davis EA, Keating B, Byrne GC, Russell M, Jones TW. Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care 1997;20:22-25
9. Wagner VM, Rosenbauer J, Grabert M, Holl RW; German Initiative on Quality Control in Pediatric Diabetology. Severe hypo-glycemia, metabolic control, and diabetes management in young children with type 1 diabetes using insulin analogsda follow-up report of a large multicenter database. Eur J Pediatr 2008;167:241-242
10. Bjørgaas M, Gimse R, Vik T, Sand T. Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycaemia. Acta Paediatr 1997;86: 148-153
11. Ryan C, Vega A, Drash A. Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics 1985;75:921-927
12. Gandrud LM, Xing D, Kollman C, et al. The Medtronic Minimed Gold continuous glucose monitoring system: an effective means to discover hypo-and hyperglycemia in children under 7 years of age. Diabetes Technol Ther 2007;9:307-316
13. DIAMOND Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 2006;23: 857-866
14. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltész G; EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multi-centre prospective registration study. Lancet 2009;373:2027-2033
15. Mauras N, Beck R, Xing D, et al.; Diabetes Research in Children Network (DirecNet) Study Group. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to, 10 years. Diabetes Care 2012;35:204-210
16. Loutseiko M, Voskanyan G, Keenan DB, Steil GM. Closed-loop insulin delivery utilizing pole placement to compensate for delays in subcutaneous insulin delivery. J Diabetes Sci Tech 2011;5:9
17. Swan KL, Dziura JD, Steil GM, et al. Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care 2009;32:240-244
18. Swan KL, Weinzimer SA, Dziura JD, et al. Effect of puberty on the pharmacody-namic and pharmacokinetic properties of insulin pump therapy inyouth withtype 1 diabetes. Diabetes Care 2008;31:44-46
19. American Diabetes Association. Standards of medical care in diabetesd2012. Diabetes Care 2012;35(Suppl. 1):S11-S63
20. Gonder-Frederick L, Nyer M, Shepard JA, Vajda K, Clarke W. Assessing fear of hypoglycemia in children with type 1 diabetes and their parents. Diabetes Manag (Lond) 2011;1:627-639
21. Kanderian SS, Weinzimer S, Voskanyan G, Steil GM. Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes. J Diabetes Sci Tech 2009;3:1047-1057
22. Kanderian SS, Weinzimer SA, Steil GM. The identifiable virtual patient model: comparison of simulation and clinical closed-loop study results. J Diabetes Sci Tech 2012; 6:371-379
23. Steil GM, Clark B, Kanderian S, Rebrin K. Modeling insulin action for development of a closed-loop artificial pancreas. Diabetes Technol Ther 2005;7:94-108
24. Castle JR, Engle JM, El Youssef J, et al. Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care 2010;33: 1282-1287